Lupin's Pithampur Unit Gets Health Canada Clearance
Lupin has said that its Pithampur unit 2 manufacturing facility located in Indore has been cleared by Health Canada after a review. “Following the review, Health Canada has maintained the compliant rating for unit 2 at Pithampur (Indore) and has issued a revised ‘Establishment License’,” Lupin said in a stock market filing.
In November 2017, Lupin had received warning letter from US Food and Drug Administration (FDA) for its manufacturing facilities in Goa and Pithampur, Indore.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
Cheaper Price 99% Purity Pharmaceutical Raw Powder Mots-C for Weight Management Factory Supplier Powder CAS 1627580-64-6 Mots-C for Muscle Building
$131.67/UNIT FOB
2026-07-20
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
PPG launches strategic review: intends to sell North American architectural coatings business with annual revenue of nearly US$1.8 billion
-
Canada's frozen snow crab export trade has performed poorly this year
-
Danning tablets have been successfully exported to Canada and entered the international mainstream drug market
-
Canada sets MRLs for pesticides such as Tiafenacil in some foods
-
NexusBioAg and MustGrow Biologics Announce Exclusive Marketing and Distribution Agreement in Canada
-
Enable the Use of Polysorbate 80 as an Emulsifying Agent
-
Canadian approved industrial grade ethanol for hand sanitizer
-
Rapeseed planting industry suffered unprecedented impact
-
Sun Pharma Halts US Expansion Amid 25 Percent Tariff Threat Net Profit Drops 20 Percent
-
Bayer Sets Aside $1.37 Billion for Roundup Lawsuits Raises 2025 Sales Forecast to €48 Billion
Recommend Reading
-
Trump Pressures 17 Pharma CEOs to Match US Drug Prices with Global Lows September 29 Deadline Set
-
JB Pharma Q1 Net Profit Surges 14 Percent to ₹202 Crore Revenue Hits ₹1094 Crore with 30 Percent EBITDA Margin
-
Mounjaro Reduces Heart Events by 8 Percent More Than Trulicity in 13,000-Patient Diabetes Trial
-
Moderna to Cut 10 Percent of Staff as COVID Vaccine Sales Plunge Stock Drops 4 Percent
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
BASF H1 Net Income Plummets 51 Percent to 887 Million Euros EBITDA Down 13 Percent as Chemical Prices Drag
-
Shipping Pressure Continues—ABS Market Prices Still Declining
-
March Brought a Faster Global Food Rule Cycle
-
Styrene-Butadiene Rubber Market Prices Fluctuate and Rise
-
Abogen Chemical Drops Gansu Haotian Acquisition Plans H1 Net Loss Narrows by 90 Percent